Remove Doctors Remove FDA Remove Governance Remove Informed Consent
article thumbnail

Risks of dispensing ivermectin

Natalia Mazina

The associations reminded the public that (1) ivermectin is not approved by the FDA for human use to prevent or treat Covid-19 and (2) Clinical trials and observational studies to evaluate the use of ivermectin to prevent and treat COVID-19 in humans have yielded insufficient evidence to recommend its use.

article thumbnail

Health Care Is Front and Center as DeSantis and Newsom Go Mano a Mano

Kaiser Health News

“We’re not going to be like California and have massive numbers of people on government programs without work requirements,” DeSantis said at a presidential primary debate in Southern California earlier this year. California bans short-term health plans. citizen or lawfully present in the country.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News – February 10, 2023

Hall Render

deal to buy national physician practice Support grows for association health plans as small employer insurance costs soar Connecticut doctors call on legislature to tackle prior authorization during this year’s session CT hospitals support student-loan forgiveness, debt-free college programs to boost healthcare workforce DC D.C.’s

article thumbnail

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

Apparently, a fraudulent foreign-trained “doctor” treated the plaintiffs, none of whom claimed malpractice or any physical injury whatsoever. Anyway, this fraudulent “doctor” allegedly “touched them without informed consent” and caused them “emotional distress. 23 in its current form. at *3) Rule 23(c)(4) partial class.

Doctors 52
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) (federal government may unilaterally obtain dismissal of FCA claims, and calling the constitutionality of the FCA’s private enforcement mechanism into question) ( here ); Quishenberry v. Instead, Zofran turned mainly on animal studies – three Japanese studies that were not “newly acquired information” that could avoid preemption.

FDA 105
article thumbnail

FDA Safety Communication Not Enough to Support Punitive Damages Claim in New Jersey

Drug & Device Law

But it involves the interplay between an FDA “Safety Communication” and punitive damages, so we thought it was worth looking at. The FDA data showed that approximately.28% Within days, the hospital convened a “power morcellation group” tasked with drafting an informed consent form that would reflect the FDA’s concerns.

FDA 59